{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:09:41Z","timestamp":1761898181306,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clinre.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T21:56:22Z","timestamp":1355262982000},"page":"189-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Infliximab infusion time in patients with inflammatory bowel diseases: Is longer really safer?"],"prefix":"10.1016","volume":"37","author":[{"given":"Mehdi","family":"Belhassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-David","family":"Zeitoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie H.","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Charachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Le Baleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iradj","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Delchier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2012.07.004_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/rheumatology\/kei247","article-title":"Shortening infusion times for infliximab administration","volume":"45","author":"Buch","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinre.2012.07.004_bib0010","first-page":"667","article-title":"Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis","volume":"29","author":"Shergy","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2012.07.004_bib0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2003.017590","article-title":"Feasibility of 1hour infliximab infusions","volume":"64","author":"Van Vollenhoven","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.clinre.2012.07.004_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MPG.0b013e31818e1914","article-title":"Rapid infliximab infusions in pediatric inflammatory bowel disease","volume":"49","author":"Yeckes","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2012.07.004_bib0025","unstructured":"Rojany M, Wegelin J, Trudeau W et al. A rapid one-hour infusion of infliximab is well tolerated. Digestive disease week 2006, May 20\u201325, 2006, Los Angeles."},{"key":"10.1016\/j.clinre.2012.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/ibd.21279","article-title":"Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?","volume":"16","author":"Bhat","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2012.07.004_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ajg.2011.61","article-title":"Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study","volume":"106","author":"Breynaert","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2012.07.004_bib0040","unstructured":"Salzberg BA, Kendall, K. Successful 1 hour infusions of infliximab for Crohn's disease patients in an outpatient office setting. Digestive disease week 2004. New Orleans, LA. Abstract 100033."},{"issue":"2","key":"10.1016\/j.clinre.2012.07.004_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2036.2011.04699.x","article-title":"A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study","volume":"34","author":"Lee","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2012.07.004_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MEG.0b013e3283081afe","article-title":"Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease","volume":"21","author":"Clare","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2012.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","article-title":"Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease","volume":"56","author":"Vermeire","year":"2007","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.clinre.2012.07.004_bib0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MEG.0b013e32832937e3","article-title":"A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab","volume":"21","author":"Mantzaris","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2012.07.004_bib0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/gast.2003.50145","article-title":"Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial","volume":"124","author":"Farrell","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112002082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112002082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:21Z","timestamp":1761895041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740112002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S2210740112002082"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2012.07.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab infusion time in patients with inflammatory bowel diseases: Is longer really safer?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2012.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}